Researchers build better flu vax for birds

A research team at the University of Maryland has developed a universal flu vaccine that can also protect birds and mammals from avian flu. The team used isolated genes from the H9N2 virus to create the vaccine "backbone," adding specific genes from other strains to customize the vaccine as needed. And making a better animal vaccine will make it easier to protect humans from a viral mutation.

"We now have a vaccine that works in many animal species and can protect against any type of influenza that we want," said team leader Daniel Perez, who works at the Virginia Maryland Regional College of Veterinary Medicine (Avian Flu Virus Program).

Research on bird flu has been a big focus in the vaccine development field for several years now. Public interest peaked a couple of years ago, when fears of a human outbreak spiked as governments rushed to stockpile drugs that had only a marginal chance of protecting their populations. But every flu season, new human cases and fresh outbreaks in bird populations in Asia spur fresh attention. This year, indications that bird vaccines are losing their ability to protect poultry in Hong Kong have raised new worries that a mutation in the virus could trigger a pandemic.

- read the story from innovations report
- and check out the story from Voice of America

ALSO: Switzerland's AmVac is working with researchers in Taiwan on a new H5N1 vaccine. AmVac's MALP-2 adjuvant, administered in a nose spray, is being used in the research. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.